[Index] [Search] [Download] [Related Items] [Help]
CRIMINAL CODE (CONTROLLED DRUGS) LEGISLATION AMENDMENT REGULATION 2014 (NO 1) (NO 6 OF 2014)
2014
THE LEGISLATIVE ASSEMBLY FOR THE
AUSTRALIAN CAPITAL TERRITORY
CRIMINAL CODE (CONTROLLED DRUGS) LEGISLATION AMENDMENT REGULATION 2014 (No 1)
SL2014—6
EXPLANATORY STATEMENT
Presented by
Simon Corbell
MLA
Attorney-General
CRIMINAL CODE (CONTROLLED DRUGS) LEGISLATION AMENDMENT REGULATION 2014 (No 1)
Overview
The Criminal Code (Controlled Drugs) Legislation Amendment
Regulation 2014 (No 1)amends the Criminal Code Regulation 2005 and
the Drugs of Dependence Regulation 2009.
The Criminal Code
Regulation 2005 specifies the substances and plants that are
‘controlled drugs’, ‘controlled plants’ and
‘controlled precursors’ pursuant to the Criminal Code 2002.
The regulation also specifies the trafficable, commercial and large commercial
quantities for each substance and plant.
The Drugs of Dependence
Regulation defines ‘drugs of dependence’ and
‘prohibited substances’ for the purposes of the Drugs of
Dependence Act 1989. It defines these terms with reference to Schedule 1 of
the Criminal Code Regulation.
This regulation implements a series of
measures to enhance the transparency and efficacy of drug enforcement,
including:
• the addition of 44 new illicit substances to the Schedule
1 of the Criminal Code Regulation;
• changing the trafficable
quantities of the 5 most common drugs (and their associated substances);
• adopting a uniform multiplier to govern the relationship between
trafficable, commercial and large commercial quantities of drugs; and
• the adoption of a ‘mixed weight’ purity regime of drug enforcement.
The regulation makes minor typographical amendments to drug names to ensure greater consistency of nomenclature. The regulation also makes minor consequential amendments to the Drugs of Dependence Regulation arising from the Criminal Code Amendment Regulation 2010.
Human rights analysis
Trafficking offences in chapter 6 of the
Criminal Code are underpinned by the Criminal Code Regulation. The Regulation
prescribes the controlled drugs and the amounts for these offences.
To
prove trafficking, the prosecution must prove that the defendant actually
trafficked drugs, (i.e. they sold the drug), or they knowingly possessed the
drug with the intention of selling it.
Section 604 of the Criminal Code
contains a ‘reverse presumption’ for drug trafficking offences. The
section provides that if a person possessed a trafficable quantity of a
controlled drug it is presumed, unless the contrary is proved, that the
defendant had the intention or belief about the sale of the drug required for
the offence.
Statutory presumptions engage and limit ‘rights in
criminal proceeding’ (section 22) in the Human Rights Act 2004.
The limitations on the right to be presumed innocent by a statutory
presumption applying to the possession of controlled precursors was extensively
address in the explanatory statement to the Crimes Legislation Amendment Bill
2012 (No 2). That analysis is relevant to the existing statutory presumption
in section 604 of the Criminal Code.
It is important that amounts
prescribed in the Criminal Code Regulation properly reflect the seriousness of
the conduct because of the rebuttable presumptions for serious criminal
offences. Prescribing substances and amounts in the schedule of controlled drugs
engages and limits rights in criminal proceeding (section 22) in the Human
Rights Act 2004.
Section 22(1) of the Human Rights Act provides that
“everyone charged with a criminal offence has the right to be presumed
innocent until proved guilty according to law.”
The effect of the
presumption of innocence in section 22(1) of the Human Rights Act and the
proportionality test require that:
• any reverse presumption dealing
with trafficable quantities of a controlled drug are rational;
• in
practical terms, there must be a ‘strong probability’ that the only
reason a person found to be in possession of a trafficable quantity has that
drug for the purpose of trafficking it;
• there must be a very low risk
that anyone in possession of a trafficable quantity would be in possession of
the drug for the purpose of personal use.
The Model Criminal Code
Officers Committee of the Standing Council of Attorneys-General addressed the
factors that inform the setting of trafficable quantities. The 1998 Report
— Chapter 6, Serious Drug offences identified the three factors as
central to the grade of criminality of the offence:
• the profit
expected from illegal activity,
• the damage to the community,
including:
o financial impact through the functioning of a black
market and the diversion of funds from legitimate to illegal business
enterprises;
o flow on crime such as property crime to finance use,
and crimes of violence resulting from market competition and
disputes;
• the damage done to the individual user.
A review of
the model drug schedules considered available evidence on these and other
factors to assist with the appropriate amounts to be prescribed.
The
trafficable thresholds under the Regulation were contrasted against four
evidence informed ways of assessing the seriousness of drug offences. The
factors considered through the review included:
• market value i.e.
amount of money that would be made by traffickers of a particular
drug;
• consumption i.e. number of doses of drug that would be
trafficked in the ACT market;
• harm to individuals and society i.e.
amount of harm that would result to ACT drug users and the community from
trafficking in a particular drug;
• social costs i.e. annual cost of
healthcare and criminality from each gram of drug that is trafficked in the
ACT.
The proposal to prescribe new amounts also considered the substances
included in the schedules of the Commonwealth, States and the Northern Territory
as well as the model schedule of drugs. Morbidity and mortality evidence was
also considered where available.
Prescribing substances and amounts with
the benefit of the analysis of the review ensures that the amendments to the
Regulation are reasonable and proportionate limitations on the right to be
presumed innocent under section 22(1) of the Human Rights Act.
NOTES
ON CLAUSES
Part 1 Preliminary
Clause 1 – Name of
regulation
This clause states that the name of the regulation is the
Criminal Code (Controlled Drugs) Legislation Amendment Regulation 2014 (No
1).
Clause 2 – Commencement
This clause states that
the regulation commences on the 7th day after notification.
Clause 3 – Legislation amended
This clause states that
the legislation amended is the Criminal Code Regulation (the Regulation)
and the Drugs of Dependence Regulation.
Part 2 Criminal Code Regulation 2005
Clause 4 –
Section 3, notes
This is a technical clause that removes the reference to
‘associated drugs’ from the notes in section 3 of the Regulation.
This term was consolidated into a wider definition of ‘controlled
drugs’ by the Criminal Code Amendment Regulation 2010.
Clause 5
– Section 9
This clause substitutes section 9 and replaces the
existing ‘pure weight’ system of drug enforcement with a
‘mixed weight’ adopted in other Australian jurisdictions. The
ability to charge based on the ‘pure weight’ is still available to
prosecutors in the event that an offence requires this calculation.
A
mixed-weight system is a more transparent way of calculating the amount of
prohibited drugs. It is also much more practical for law enforcement.
Clause 6 – New part 10
This clause inserts transitional provisions to clarify that the amended regulation will apply to offences committed on or after the commencement day of the regulation, or to offences which have been committed between dates if either of those dates is on or after the commencement date.
These transitional provisions expire 2 years after the commencement of the
amendments to the Regulation.
Clause 7 – Schedules 1 to 3
This clause substitutes Schedule 1 and Schedule 2 of the Regulation.
The
new section adds 44 new substances to Schedule 1. These substances are:
NO.
|
Proposed new Substance
|
Common Name
|
Traf. Amt
|
---|---|---|---|
1
|
Alpha-Pyrrolidinovalerophenone
|
(a-PVP)
|
6g
|
2
|
N-acetylmethylamphetamine
|
|
6g
|
3
|
N-formylmethylamphetamine
|
|
6g
|
4
|
N-acetylamphetamine
|
|
6g
|
5
|
N-formylamphetamine
|
|
6g
|
6
|
Methcathinone
|
|
6g
|
7
|
1-(3-Chlorophenyl)-piperazine
|
mCPP
|
6g
|
8
|
1-(4-Methoxyphenyl)piperazine
|
pMPP
|
6g
|
9
|
4-Bromo-2,5-dimethoxyamphetamine
|
DOB
|
10g
|
10
|
4-Fluoro-N-methylamphetamine
|
4-FMA
|
10g
|
11
|
2,5-Dimethoxy-4-ethylamphetamine
|
DOET
|
10g
|
12
|
4-Methoxymethylamphetamine
|
PMMA
|
10g
|
13
|
Phenethylamines (not otherwise listed in this schedule)
|
|
300g
|
14
|
2,5-Dimethoxy-4-ethylthiophenethylamine
|
2C-T-2
|
10g
|
15
|
2,5-Dimethoxy-4-iodophenethylamine
|
2C-I
|
10g
|
16
|
2,5-Dimethoxy-4-(N)-propylthiophenethylamine
|
2C-T-7
|
10g
|
17
|
1-(8-Bromobenzo[1,2-b;4,5-b]difuran-4-yl)-2-aminopropane
|
Bromo-Dragonfly
|
10g
|
18
|
3,4-Methylenedioxypyrovalerone
|
MDPV
|
10g
|
19
|
4-Methylmethcathinone
|
Mephedrone
|
6g
|
20
|
3,4-Methylenedioxymethcathinone
|
Methylone
|
10g
|
21
|
Nalbuphine
|
|
0.05g
|
22
|
Cannabinomimetics (Synthetic) except when separately specified in these
Schedules
|
|
300g
|
23
|
Benzoylindoles except when separately specified in these Schedules
|
|
300g
|
24
|
1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole
|
AM-694
|
300g
|
25
|
Dibenzopyrans except when separately specified in these Schedules
|
|
2g
|
26
|
Cyclohexylphenols except when separately specified in these Schedules
|
|
300g
|
27
|
2-[(1r,3s)-3-Hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol
(Cannabicyclohexanol or CP 47, 497 C8 homologue)
|
|
3g
|
28
|
2-[(1r,3s)-3-Hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol (CP 47,497)
|
|
3g
|
29
|
Naphthoylindoles except when separately specified in these Schedules
|
|
3g
|
30
|
1-Pentyl-3-(4-methyl-1-napthoyl)indole
|
JWH-122
|
3g
|
31
|
1-Pentyl-3-(1-naphthoyl)indole (JWH-018)
|
JWH-018
|
3g
|
32
|
Naphthylmethylindoles except when separately specified in these
Schedules
|
|
300g
|
33
|
Napthalen-1-yl-(1-butylindol-3-yl)methanone
|
JWH-073
|
3g
|
34
|
(1-(2-Morpholin-4-ylethyl)indol-3-yl)-napthalen-1-ylmethanone
|
JWH-200
|
3g
|
35
|
2-(2-Methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone (JWH-250)
|
JWH-250
|
3g
|
36
|
Naphthoylpyrroles except when separately specified in these Schedules
|
|
300g
|
37
|
Naphthylmethylindenes except when separately specified in these Schedules
|
|
300g
|
38
|
Phenylacetylindoles except when separately specified in these
Schedules
|
|
300g
|
39
|
5-Methoxy-alpha-methyltryptamine
|
5-MeO-AMT
|
10g
|
40
|
N-(2-Methoxybenzyl)-2,5-dimethoxy-4-chlorophenethylamine
|
25C-NBOMe
|
10g
|
41
|
N-(2-Methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine
|
25I-NBOMe
|
10g
|
42
|
N-(2-Methoxybenzyl)-2,5-dimethoxy-4-bromophenethylamine
|
25B-NBOMe
|
10g
|
43
|
N-(2-Methoxybenzyl)-2,5-dimethoxy-4-methylphenethylamine
|
25D-NBOMe
|
10g
|
44
|
N-(2-Methoxybenzyl)-2,5-dimethoxyphenethylamine 25H-NBOMe
|
25H-NBOMe
|
10g
|
In reforming the threshold quantities, the Amendment Regulation also
adopts a broadly uniform multiplier. The commercial quantity of a substance is
now 500 times the trafficable quantity. The large commercial quantity is 2 times
the commercial quantity. Cannabis will use its own multipliers to reflect the
characteristics of trafficking in that drug.
The new section modifies the
trafficable amounts of the 5 most common controlled drugs and all 118 of their
associated substances. The new amounts for the 5 most common drugs are as
follows:
Controlled Drug
|
Old trafficable amount (pure)
|
New trafficable amount (mixed)
|
Heroin
|
2g
|
5g
|
Methamphetamine
|
2g
|
6g
|
Cocaine
|
2g
|
6g
|
MDMA
|
0.5g
|
10g
|
Cannabis
|
300g
|
300g
|
The new schedules also consolidate a small number of chemicals to avoid duplication for compounds where different names can be used.
While 44 new chemicals have been added to the schedule, the total number of listed substances in schedule 1.2 is now 185 (previously 145 substances), an overall difference of 39 substances.
Minor typographical amendments to existing substances to ensure greater consistency have also been made.
Part 3 Drugs of Dependence Regulation 2009
Part 3 makes a number of minor amendments to the Drugs of Dependence Act to
give effect to the Criminal Code Amendment Regulation 2010.
Clause 8
– Section 4(b)
This clause replaces the reference to
‘associated drugs’ with ‘related drugs’. This operates
with clause 9 to remove the term ‘associated drugs’ from section
4.
Clause 9 – Section 4(c)
This clause removes section
4(c). This operates with clause 8 to remove the term ‘associated
drugs’ from section 4.
Clause 10 – Section
5(b)
This clause replaces the reference to ‘associated drugs’
with ‘related drugs’. This operates with clause 11 to remove the
term ‘associated drugs’ from section 4.
Clause 11 –
Section 5(c)
This clause removes section 5(c). This operates with clause
10 to remove the term ‘associated drugs’ from section 5.